HEADER TRANSFERASE 08-SEP-06 2IAJ TITLE CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE TITLE 2 (RT) IN COMPLEX WITH ATP COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H (P66 RT); COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: P66; COMPND 5 EC: 2.7.7.49; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H; P51 RT; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: P51; COMPND 12 EC: 2.7.7.49; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 BH10; SOURCE 3 ORGANISM_TAXID: 11678; SOURCE 4 STRAIN: BH10 ISOLATE; SOURCE 5 GENE: POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 BH10; SOURCE 10 ORGANISM_TAXID: 11678; SOURCE 11 STRAIN: BH10 ISOLATE; SOURCE 12 GENE: POL; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS RT, NNRTI, NONNUCLEOSIDE INHIBITOR, DRUG RESISTANCE, DNA KEYWDS 2 POLYMERIZATION, HIV, AIDS, DRUG DESIGN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.DAS,E.ARNOLD REVDAT 6 30-AUG-23 2IAJ 1 REMARK REVDAT 5 20-OCT-21 2IAJ 1 REMARK SEQADV LINK REVDAT 4 18-OCT-17 2IAJ 1 REMARK REVDAT 3 13-JUL-11 2IAJ 1 VERSN REVDAT 2 24-FEB-09 2IAJ 1 VERSN REVDAT 1 19-DEC-06 2IAJ 0 JRNL AUTH K.DAS,S.G.SARAFIANOS,A.D.CLARK,P.L.BOYER,S.H.HUGHES,E.ARNOLD JRNL TITL CRYSTAL STRUCTURES OF CLINICALLY RELEVANT JRNL TITL 2 LYS103ASN/TYR181CYS DOUBLE MUTANT HIV-1 REVERSE JRNL TITL 3 TRANSCRIPTASE IN COMPLEXES WITH ATP AND NON-NUCLEOSIDE JRNL TITL 4 INHIBITOR HBY 097. JRNL REF J.MOL.BIOL. V. 365 77 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17056061 JRNL DOI 10.1016/J.JMB.2006.08.097 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Y.HSIOU,J.DING,K.DAS,A.D CLARK,S.H.HUGHES,E.ARNOLD REMARK 1 TITL STRUCTURE OF UNLIGANDED HIV-1 REVERSE TRANSCRIPTASE AT 2.7 A REMARK 1 TITL 2 RESOLUTION: IMPLICATIONS OF CONFORMATIONAL CHANGES FOR REMARK 1 TITL 3 POLYMERIZATION AND INHIBITION MECHANISMS REMARK 1 REF STRUCTURE V. 4 853 1996 REMARK 1 REFN ISSN 0969-2126 REMARK 1 PMID 8805568 REMARK 1 DOI 10.1016/S0969-2126(96)00091-3 REMARK 1 REFERENCE 2 REMARK 1 AUTH K.DAS,J.DING,Y.HSIOU,A.D.CLARK,H.MOEREELS,L.KOYMANS, REMARK 1 AUTH 2 K.ANDRIES,R.PAUWELS,P.A.JANSSEN,P.L.BOYER,P.CLARK,R.H.SMITH, REMARK 1 AUTH 3 M.B.KROEGER SMITH,C.J.MICHEJDA,S.H.HUGHES,E.ARNOLD REMARK 1 TITL CRYSTAL STRUCTURES OF 8-CL AND 9-CL TIBO COMPLEXED WITH REMARK 1 TITL 2 WILD-TYPE HIV-1 RT AND 8-CL TIBO COMPLEXED WITH THE REMARK 1 TITL 3 TYR181CYS HIV-1 RT DRUG-RESISTANT MUTANT. REMARK 1 REF J.MOL.BIOL. V. 264 1085 1996 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 9000632 REMARK 1 DOI 10.1006/JMBI.1996.0698 REMARK 1 REFERENCE 3 REMARK 1 AUTH Y.HSIOU,K.DAS,J.DING,A.D.CLARK,J.P.KLEIM,I.WINKLER,G.RIESS, REMARK 1 AUTH 2 S.H.HUGHES,E.ARNOLD REMARK 1 TITL STRUCTURES OF TYR188LEU MUTANT AND WILD-TYPE HIV-1 REVERSE REMARK 1 TITL 2 TRANSCRIPTASE COMPLEXED WITH THE NON-NUCLEOSIDE INHIBITOR REMARK 1 TITL 3 HBY 097: INHIBITOR FLEXIBILITY IS A USEFUL DESIGN FEATURE REMARK 1 TITL 4 FOR REDUCING DRUG RESISTANCE. REMARK 1 REF J.MOL.BIOL. V. 284 313 1998 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 9813120 REMARK 1 DOI 10.1006/JMBI.1998.2171 REMARK 1 REFERENCE 4 REMARK 1 AUTH Y.HSIOU,J.DING,K.DAS,A.D.CLARK,P.L.BOYER,P.LEWI,P.A.JANSSEN, REMARK 1 AUTH 2 J.P.KLEIM,S.H.HUGHES,E.ARNOLD REMARK 1 TITL THE LYS103ASN MUTATION OF HIV-1 RT: A NOVEL MECHANISM OF REMARK 1 TITL 2 DRUG RESISTANCE. REMARK 1 REF J.MOL.BIOL. V. 309 437 2001 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 11371163 REMARK 1 DOI 10.1006/JMBI.2001.4648 REMARK 1 REFERENCE 5 REMARK 1 AUTH K.DAS,A.D.CLARK,P.J.LEWI,J.HEERES,M.R.DE JONGE,L.M.KOYMANS, REMARK 1 AUTH 2 H.M.VINKERS,F.DAEYAERT,D.W.LUDOVICI,M.J.KUKLA,B.DE CORTE, REMARK 1 AUTH 3 R.W.KAVASH,C.Y.HO,H.YE,M.A.LICHTENSTEIN,K.ANDRIES,R.PAUWELS, REMARK 1 AUTH 4 P.L.BOYER,P.CLARK,S.H.HUGHES,P.A.JANSSEN,E.ARNOLD REMARK 1 TITL ROLES OF CONFORMATIONAL AND POSITIONAL ADAPTABILITY IN REMARK 1 TITL 2 STRUCTURE-BASED DESIGN OF TMC125-R165335 (ETRAVIRINE) AND REMARK 1 TITL 3 RELATED NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS THAT REMARK 1 TITL 4 ARE HIGHLY POTENT AND EFFECTIVE AGAINST WILD-TYPE AND REMARK 1 TITL 5 DRUG-RESISTANT HIV-1 VARIANTS. REMARK 1 REF J.MED.CHEM. V. 47 2550 2004 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 15115397 REMARK 1 DOI 10.1021/JM030558S REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 789848.625 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 85.6 REMARK 3 NUMBER OF REFLECTIONS : 45021 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1817 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 59.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4953 REMARK 3 BIN R VALUE (WORKING SET) : 0.4560 REMARK 3 BIN FREE R VALUE : 0.4850 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 192 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.035 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7822 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 47 REMARK 3 SOLVENT ATOMS : 308 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 72.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.15000 REMARK 3 B22 (A**2) : -4.88000 REMARK 3 B33 (A**2) : 5.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 18.59000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM SIGMAA (A) : 0.79 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.52 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.93 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.100 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.360 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.950 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.580 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.260 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.28 REMARK 3 BSOL : 40.37 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : ATP.PAR REMARK 3 PARAMETER FILE 5 : GOL.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ATP.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : GOL.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2IAJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-SEP-06. REMARK 100 THE DEPOSITION ID IS D_1000039342. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-OCT-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48538 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 68.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.36700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1DLO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, BIS_TRIS PROPANE, AMMONIUM REMARK 280 SULFATE, GLYCEROL, MNCL2, ATP, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K, PH 6.8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 118.70000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.56500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 118.70000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.56500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: P66/P51 HETERO DIMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 45510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -53.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 552 REMARK 465 SER A 553 REMARK 465 ALA A 554 REMARK 465 GLY A 555 REMARK 465 ILE A 556 REMARK 465 ARG A 557 REMARK 465 LYS A 558 REMARK 465 ILE A 559 REMARK 465 LEU A 560 REMARK 465 LYS B 220 REMARK 465 HIS B 221 REMARK 465 GLN B 222 REMARK 465 LYS B 223 REMARK 465 GLU B 224 REMARK 465 PRO B 225 REMARK 465 PRO B 226 REMARK 465 PHE B 227 REMARK 465 LEU B 228 REMARK 465 TRP B 229 REMARK 465 MET B 230 REMARK 465 GLY B 231 REMARK 465 GLN B 428 REMARK 465 LEU B 429 REMARK 465 GLU B 430 REMARK 465 LYS B 431 REMARK 465 GLU B 432 REMARK 465 PRO B 433 REMARK 465 ILE B 434 REMARK 465 VAL B 435 REMARK 465 GLY B 436 REMARK 465 ALA B 437 REMARK 465 GLU B 438 REMARK 465 THR B 439 REMARK 465 PHE B 440 REMARK 465 TYR B 441 REMARK 465 VAL B 442 REMARK 465 ASP B 443 REMARK 465 GLY B 444 REMARK 465 ALA B 445 REMARK 465 ALA B 446 REMARK 465 ASN B 447 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 28 CG CD OE1 OE2 REMARK 470 GLU A 36 CG CD OE1 OE2 REMARK 470 GLU A 40 CG CD OE1 OE2 REMARK 470 GLU A 44 CG CD OE1 OE2 REMARK 470 LYS A 64 CG CD CE NZ REMARK 470 LYS A 65 CG CD CE NZ REMARK 470 LYS A 66 CG CD CE NZ REMARK 470 LYS A 70 CG CD CE NZ REMARK 470 ARG A 72 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 177 CG OD1 OD2 REMARK 470 GLU A 291 CG CD OE1 OE2 REMARK 470 GLU A 297 CG CD OE1 OE2 REMARK 470 GLU A 305 CG CD OE1 OE2 REMARK 470 LYS A 550 CG CD CE NZ REMARK 470 LEU B 295 CG CD1 CD2 REMARK 470 THR B 296 OG1 CG2 REMARK 470 GLU B 297 CG CD OE1 OE2 REMARK 470 GLU B 305 CG CD OE1 OE2 REMARK 470 GLN B 334 CG CD OE1 NE2 REMARK 470 MET B 357 CG SD CE REMARK 470 THR B 362 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O VAL B 90 N LEU B 92 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 52 C - N - CA ANGL. DEV. = 10.8 DEGREES REMARK 500 GLU B 89 N - CA - C ANGL. DEV. = -24.5 DEGREES REMARK 500 PRO B 420 C - N - CA ANGL. DEV. = 9.4 DEGREES REMARK 500 PRO B 420 C - N - CD ANGL. DEV. = -13.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 31 -2.67 -49.19 REMARK 500 GLU A 44 -4.40 -56.06 REMARK 500 LYS A 46 -70.19 -70.78 REMARK 500 PRO A 52 -76.19 -54.59 REMARK 500 GLU A 53 7.07 -64.41 REMARK 500 LYS A 66 -27.16 -38.49 REMARK 500 GLU A 89 133.28 -34.91 REMARK 500 GLN A 91 111.00 -24.52 REMARK 500 LEU A 92 1.94 -61.43 REMARK 500 PRO A 133 -178.81 -52.96 REMARK 500 GLU A 138 -52.41 -121.12 REMARK 500 PRO A 140 40.17 -71.22 REMARK 500 MET A 184 -128.17 74.33 REMARK 500 ILE A 195 -41.88 -26.17 REMARK 500 ASP A 218 -12.15 -48.51 REMARK 500 GLN A 222 -7.27 -37.66 REMARK 500 MET A 230 12.15 57.33 REMARK 500 ALA A 288 150.36 -45.50 REMARK 500 LEU A 310 -0.50 -56.23 REMARK 500 GLN A 334 69.03 39.88 REMARK 500 ARG A 356 159.17 -46.40 REMARK 500 PRO A 392 43.24 -84.59 REMARK 500 PRO A 412 -171.61 -62.79 REMARK 500 ALA A 445 147.32 -173.00 REMARK 500 GLU A 449 -98.98 -91.58 REMARK 500 THR A 450 -18.59 -37.54 REMARK 500 VAL A 458 119.43 -161.55 REMARK 500 LYS A 461 9.57 -65.84 REMARK 500 ILE A 542 -153.42 -79.39 REMARK 500 SER B 3 -67.71 -122.61 REMARK 500 PRO B 4 34.46 -96.87 REMARK 500 LYS B 65 94.96 -53.84 REMARK 500 ASP B 67 54.55 86.81 REMARK 500 PHE B 77 21.09 -77.47 REMARK 500 VAL B 90 43.88 36.42 REMARK 500 GLN B 91 4.03 -48.10 REMARK 500 ILE B 94 68.29 -114.16 REMARK 500 TYR B 115 -46.08 -29.83 REMARK 500 PHE B 116 19.81 -63.66 REMARK 500 GLN B 161 -71.53 -41.13 REMARK 500 LYS B 166 -9.05 -58.17 REMARK 500 MET B 184 -127.18 46.75 REMARK 500 ARG B 199 -9.52 -57.33 REMARK 500 THR B 286 52.53 -157.84 REMARK 500 GLU B 291 104.21 -45.65 REMARK 500 VAL B 292 107.15 -56.71 REMARK 500 ILE B 309 -19.97 -40.21 REMARK 500 LEU B 310 42.12 -88.90 REMARK 500 VAL B 314 150.78 -36.64 REMARK 500 HIS B 315 85.25 -65.76 REMARK 500 REMARK 500 THIS ENTRY HAS 58 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 564 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 LYS A 101 O REMARK 620 2 ASN A 103 N 80.0 REMARK 620 3 ASN A 103 OD1 61.3 73.3 REMARK 620 4 TYR A 188 OH 119.0 124.1 73.2 REMARK 620 5 HOH A 663 O 114.8 89.6 162.8 119.6 REMARK 620 6 HOH A 667 O 139.6 133.5 138.9 65.8 55.8 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A 561 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 110 OD1 REMARK 620 2 ASP A 185 OD1 104.1 REMARK 620 3 ASP A 186 OD1 69.3 97.5 REMARK 620 4 ATP A 601 O2B 100.9 79.1 168.7 REMARK 620 5 ATP A 601 N7 173.6 77.8 104.5 85.5 REMARK 620 6 HOH A 602 O 69.1 170.8 74.5 107.8 108.4 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A 562 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 110 OD2 REMARK 620 2 VAL A 111 O 88.2 REMARK 620 3 ASP A 185 OD2 94.3 85.8 REMARK 620 4 ATP A 601 O2B 98.4 161.7 76.7 REMARK 620 5 ATP A 601 O3G 94.6 86.4 167.9 109.9 REMARK 620 6 ATP A 601 O2A 173.9 85.8 86.0 87.6 84.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A 563 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 443 OD2 REMARK 620 2 GLU A 478 OE2 67.6 REMARK 620 3 ASP A 498 OD1 93.7 70.5 REMARK 620 4 ASP A 498 OD2 111.7 130.3 59.8 REMARK 620 5 HOH A 603 O 72.4 130.5 140.8 90.9 REMARK 620 6 HOH A 749 O 105.3 87.5 143.0 134.6 76.0 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN A 561 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN A 562 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN A 563 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 564 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SV5 RELATED DB: PDB REMARK 900 1SV5 IS THE STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE REMARK 900 IN COMPLEX WITH JANSSEN-R165335 REMARK 900 RELATED ID: 1DLO RELATED DB: PDB REMARK 900 1DLO IS THE STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 RELATED ID: 2IC3 RELATED DB: PDB REMARK 900 2IC3 IS THE STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE REMARK 900 TRANSCRIPTASE IN COMPLEX WITH NONNUCLEOSIDE INHIBITOR HBY 097 REMARK 900 RELATED ID: 1BQM RELATED DB: PDB REMARK 900 1S9E IS THE STRUCTURE OF HIV-1 RT/HBY 097 REMARK 900 RELATED ID: 1UWB RELATED DB: PDB REMARK 900 1HNV IS THE STRUCTURE OF TYR 181 CYS HIV-1 RT/8-CL TIBO REMARK 900 RELATED ID: 2HMI RELATED DB: PDB REMARK 900 2HMI IS HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH A DOUBLE- REMARK 900 STRANDED DNA AND FAB28 DBREF 2IAJ A 1 560 UNP P03366 POL_HV1B1 599 1158 DBREF 2IAJ B 1 447 UNP P03366 POL_HV1B1 599 1045 SEQADV 2IAJ ASN A 103 UNP P03366 LYS 701 ENGINEERED MUTATION SEQADV 2IAJ CYS A 181 UNP P03366 TYR 779 ENGINEERED MUTATION SEQADV 2IAJ SER A 280 UNP P03366 CYS 878 ENGINEERED MUTATION SEQADV 2IAJ ASN B 103 UNP P03366 LYS 701 ENGINEERED MUTATION SEQADV 2IAJ CYS B 181 UNP P03366 TYR 779 ENGINEERED MUTATION SEQADV 2IAJ SER B 280 UNP P03366 CYS 878 ENGINEERED MUTATION SEQRES 1 A 560 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 A 560 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 A 560 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 A 560 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 A 560 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 A 560 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 A 560 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 A 560 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS ASN LYS SEQRES 9 A 560 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 A 560 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 A 560 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 A 560 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 A 560 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 A 560 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE CYS GLN SEQRES 15 A 560 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 A 560 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 A 560 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 A 560 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 A 560 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 A 560 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 A 560 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 A 560 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 A 560 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 A 560 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 A 560 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 A 560 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 A 560 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 A 560 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 A 560 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 A 560 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 A 560 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 A 560 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 A 560 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 A 560 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL SEQRES 35 A 560 ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA SEQRES 36 A 560 GLY TYR VAL THR ASN LYS GLY ARG GLN LYS VAL VAL PRO SEQRES 37 A 560 LEU THR ASN THR THR ASN GLN LYS THR GLU LEU GLN ALA SEQRES 38 A 560 ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN SEQRES 39 A 560 ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN SEQRES 40 A 560 ALA GLN PRO ASP LYS SER GLU SER GLU LEU VAL ASN GLN SEQRES 41 A 560 ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU SEQRES 42 A 560 ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU SEQRES 43 A 560 GLN VAL ASP LYS LEU VAL SER ALA GLY ILE ARG LYS ILE SEQRES 44 A 560 LEU SEQRES 1 B 447 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 447 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 447 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 447 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 447 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 447 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 447 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 447 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS ASN LYS SEQRES 9 B 447 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 447 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 447 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 447 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 447 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 447 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE CYS GLN SEQRES 15 B 447 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 447 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 447 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 447 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 447 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 447 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 447 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 447 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 B 447 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 447 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 447 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 447 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 447 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 447 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 447 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 447 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 447 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 447 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 447 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 B 447 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL SEQRES 35 B 447 ASP GLY ALA ALA ASN HET MN A 561 1 HET MN A 562 1 HET MN A 563 1 HET NA A 564 1 HET ATP A 601 31 HET GOL B 501 6 HET GOL B 502 6 HETNAM MN MANGANESE (II) ION HETNAM NA SODIUM ION HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 MN 3(MN 2+) FORMUL 6 NA NA 1+ FORMUL 7 ATP C10 H16 N5 O13 P3 FORMUL 8 GOL 2(C3 H8 O3) FORMUL 10 HOH *308(H2 O) HELIX 1 1 GLU A 29 GLY A 45 1 17 HELIX 2 2 PHE A 77 ARG A 83 1 7 HELIX 3 3 HIS A 96 LEU A 100 5 5 HELIX 4 4 ALA A 114 VAL A 118 5 5 HELIX 5 5 ASP A 121 ALA A 129 5 9 HELIX 6 6 GLY A 155 ASN A 175 1 21 HELIX 7 7 GLU A 194 ARG A 211 1 18 HELIX 8 8 THR A 253 SER A 268 1 16 HELIX 9 9 VAL A 276 LYS A 281 1 6 HELIX 10 10 THR A 296 LEU A 310 1 15 HELIX 11 11 ASN A 363 GLY A 384 1 22 HELIX 12 12 GLN A 394 TYR A 405 1 12 HELIX 13 13 THR A 473 ASP A 488 1 16 HELIX 14 14 SER A 499 ALA A 508 1 10 HELIX 15 15 SER A 515 LYS A 528 1 14 HELIX 16 16 ILE A 542 VAL A 548 1 7 HELIX 17 17 THR B 27 GLU B 44 1 18 HELIX 18 18 PHE B 77 THR B 84 1 8 HELIX 19 19 VAL B 90 ILE B 94 5 5 HELIX 20 20 GLY B 99 ASN B 103 5 5 HELIX 21 21 GLY B 112 VAL B 118 5 7 HELIX 22 22 PHE B 124 ALA B 129 5 6 HELIX 23 23 SER B 134 GLU B 138 5 5 HELIX 24 24 LYS B 154 ASN B 175 1 22 HELIX 25 25 GLU B 194 ARG B 211 1 18 HELIX 26 26 HIS B 235 TRP B 239 5 5 HELIX 27 27 VAL B 254 SER B 268 1 15 HELIX 28 28 VAL B 276 LEU B 283 1 8 HELIX 29 29 GLU B 298 LEU B 310 1 13 HELIX 30 30 ASN B 363 GLY B 384 1 22 HELIX 31 31 GLN B 394 TRP B 402 1 9 HELIX 32 32 THR B 403 TYR B 405 5 3 HELIX 33 33 PRO B 420 LYS B 424 5 5 SHEET 1 A 3 ILE A 47 LYS A 49 0 SHEET 2 A 3 ILE A 142 TYR A 146 -1 O GLN A 145 N SER A 48 SHEET 3 A 3 PHE A 130 ILE A 132 -1 N PHE A 130 O TYR A 144 SHEET 1 B 2 VAL A 60 LYS A 64 0 SHEET 2 B 2 TRP A 71 VAL A 75 -1 O ARG A 72 N ILE A 63 SHEET 1 C 3 SER A 105 LEU A 109 0 SHEET 2 C 3 ASP A 186 SER A 191 -1 O LEU A 187 N LEU A 109 SHEET 3 C 3 VAL A 179 TYR A 183 -1 N VAL A 179 O GLY A 190 SHEET 1 D 4 PHE A 227 TRP A 229 0 SHEET 2 D 4 TYR A 232 LEU A 234 -1 O LEU A 234 N PHE A 227 SHEET 3 D 4 TRP A 239 VAL A 241 -1 O THR A 240 N GLU A 233 SHEET 4 D 4 HIS A 315 GLY A 316 -1 O GLY A 316 N TRP A 239 SHEET 1 E 5 LYS A 347 ALA A 355 0 SHEET 2 E 5 GLN A 336 GLU A 344 -1 N ILE A 341 O LYS A 350 SHEET 3 E 5 ILE A 326 GLN A 332 -1 N GLN A 330 O THR A 338 SHEET 4 E 5 LYS A 388 LEU A 391 1 O LYS A 390 N ALA A 327 SHEET 5 E 5 TRP A 414 PHE A 416 1 O GLU A 415 N LEU A 391 SHEET 1 F 2 HIS A 361 THR A 362 0 SHEET 2 F 2 LYS A 512 SER A 513 -1 O LYS A 512 N THR A 362 SHEET 1 G 5 GLN A 464 LEU A 469 0 SHEET 2 G 5 GLY A 453 THR A 459 -1 N GLY A 453 O LEU A 469 SHEET 3 G 5 GLU A 438 ALA A 446 -1 N ALA A 445 O LYS A 454 SHEET 4 G 5 GLU A 492 THR A 497 1 O ASN A 494 N PHE A 440 SHEET 5 G 5 LYS A 530 TRP A 535 1 O TYR A 532 N ILE A 495 SHEET 1 H 3 ILE B 47 LYS B 49 0 SHEET 2 H 3 ILE B 142 TYR B 146 -1 O GLN B 145 N SER B 48 SHEET 3 H 3 PHE B 130 ILE B 132 -1 N ILE B 132 O ILE B 142 SHEET 1 I 2 VAL B 60 ILE B 63 0 SHEET 2 I 2 ARG B 72 VAL B 75 -1 O LEU B 74 N PHE B 61 SHEET 1 J 4 VAL B 179 TYR B 183 0 SHEET 2 J 4 ASP B 186 SER B 191 -1 O TYR B 188 N CYS B 181 SHEET 3 J 4 SER B 105 ASP B 110 -1 N LEU B 109 O LEU B 187 SHEET 4 J 4 GLU B 233 LEU B 234 -1 O LEU B 234 N VAL B 106 SHEET 1 K 2 TRP B 252 THR B 253 0 SHEET 2 K 2 VAL B 292 ILE B 293 -1 O ILE B 293 N TRP B 252 SHEET 1 L 5 ASN B 348 TYR B 354 0 SHEET 2 L 5 TRP B 337 TYR B 342 -1 N TYR B 339 O GLY B 352 SHEET 3 L 5 ILE B 326 LYS B 331 -1 N ILE B 326 O TYR B 342 SHEET 4 L 5 LYS B 388 LEU B 391 1 O LYS B 390 N ALA B 327 SHEET 5 L 5 TRP B 414 PHE B 416 1 O GLU B 415 N LEU B 391 LINK O LYS A 101 NA NA A 564 1555 1555 2.62 LINK N ASN A 103 NA NA A 564 1555 1555 2.69 LINK OD1 ASN A 103 NA NA A 564 1555 1555 2.62 LINK OD1 ASP A 110 MN MN A 561 1555 1555 2.44 LINK OD2 ASP A 110 MN MN A 562 1555 1555 2.09 LINK O VAL A 111 MN MN A 562 1555 1555 1.90 LINK OD1 ASP A 185 MN MN A 561 1555 1555 2.07 LINK OD2 ASP A 185 MN MN A 562 1555 1555 2.06 LINK OD1 ASP A 186 MN MN A 561 1555 1555 2.07 LINK OH TYR A 188 NA NA A 564 1555 1555 2.71 LINK OD2 ASP A 443 MN MN A 563 1555 1555 2.53 LINK OE2 GLU A 478 MN MN A 563 1555 1555 2.42 LINK OD1 ASP A 498 MN MN A 563 1555 1555 2.30 LINK OD2 ASP A 498 MN MN A 563 1555 1555 2.12 LINK MN MN A 561 O2B ATP A 601 1555 1555 2.19 LINK MN MN A 561 N7 ATP A 601 1555 1555 2.50 LINK MN MN A 561 O HOH A 602 1555 1555 2.23 LINK MN MN A 562 O2B ATP A 601 1555 1555 2.44 LINK MN MN A 562 O3G ATP A 601 1555 1555 2.49 LINK MN MN A 562 O2A ATP A 601 1555 1555 2.32 LINK MN MN A 563 O HOH A 603 1555 1555 2.42 LINK MN MN A 563 O HOH A 749 1555 1555 2.08 LINK NA NA A 564 O HOH A 663 1555 1555 2.74 LINK NA NA A 564 O HOH A 667 1555 1555 2.70 CISPEP 1 PRO A 225 PRO A 226 0 0.13 CISPEP 2 PRO A 420 PRO A 421 0 -0.28 SITE 1 AC1 5 ASP A 110 ASP A 185 ASP A 186 ATP A 601 SITE 2 AC1 5 HOH A 602 SITE 1 AC2 4 ASP A 110 VAL A 111 ASP A 185 ATP A 601 SITE 1 AC3 5 ASP A 443 GLU A 478 ASP A 498 HOH A 603 SITE 2 AC3 5 HOH A 749 SITE 1 AC4 6 LYS A 101 LYS A 102 ASN A 103 TYR A 188 SITE 2 AC4 6 HOH A 663 HOH A 667 SITE 1 AC5 13 ASP A 110 VAL A 111 GLY A 112 ASP A 113 SITE 2 AC5 13 ALA A 114 TYR A 115 GLN A 151 MET A 184 SITE 3 AC5 13 ASP A 185 ASP A 186 LYS A 219 MN A 561 SITE 4 AC5 13 MN A 562 SITE 1 AC6 6 VAL B 75 PHE B 77 ARG B 78 ASN B 81 SITE 2 AC6 6 GLY B 152 ILE B 411 SITE 1 AC7 4 ILE B 31 LYS B 32 ILE B 135 HOH B 557 CRYST1 237.400 71.130 94.210 90.00 105.86 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004212 0.000000 0.001197 0.00000 SCALE2 0.000000 0.014059 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011035 0.00000